Bio Rad Laboratories Inc (NYSE:BIO)
| 304.59 Delayed Data As of Nov 28 |  +0.19 / +0.06%Today’s Change | 261.59 Today|||52-Week Range 509.62 | -27.56% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 2.0B | 2.1B | 2.2B | 2.3B | |
| Cost of Goods Sold | 735.4M | 751.7M | 824.3M | 928.3M | ||
| Depreciation And Amortization | 131.8M | 142.9M | 148.7M | 138.1M | ||
| Operating Expenses | Gross Income | 1.2B | 1.2B | 1.2B | 1.2B | |
| General Expenses | 960.6M | 1.0B | 1.1B | 1.0B | ||
| Other Operating Expenses | 30.6M | 33.4M | 0.00 | 0.00 | ||
| Research And Development | 193.0M | 205.9M | 250.3M | 199.2M | ||
| Total Operating Expenses | 1.9B | 1.9B | 2.0B | 2.1B | ||
| Non-Operating Expenses | Operating Income | 161.1M | 127.6M | 128.7M | 182.8M | |
| Extraordinary Credit | 5.6M | 400.0K | 0.00 | 612.6M | ||
| Extraordinary Charge | -600.0K | -75.4M | -19.0M | -293.3M | ||
| Interest Expense On Debt | 21.7M | 21.9M | 21.9M | 24.0M | ||
| Other Expenses | -8.7M | -3.8M | -9.0M | 7.9M | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | 145.8M | 41.6M | 97.8M | 512.7M | |
| Income Taxes | -32.8M | -13.4M | -24.4M | -147.0M | ||
| Net Income | 113.1M | 28.1M | 122.2M | 365.6M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 29.2M | 29.4M | 29.7M | 29.8M | |
| Shares To Calculate EPS Diluted | 29.4M | 29.6M | 30.0M | 30.2M | ||
| Earnings Per Share | EPS | $3.85 | $0.95 | $4.07 | -- | |
| EPS Diluted | $3.85 | $0.95 | $4.07 | $12.10 | ||
